HONG KONG, April 11, 2026 /PRNewswire/ -- DPC Dash Ltd – Domino's Pizza China ("DPC Dash" or the "Company", and together with its subsidiaries, the "Group") (1405.HK), Domino's exclusive master franchisee for the Chinese mainland, Hong Kong and Macau, continued to unlock the potential of China's underpenetrated pizza market amid a complex and evolving consumption landscape in Q1 2026. Backed by its proven 4D strategy – Development, Delicious Pizza at Value, Delivery, and Digital – the Company delivered simultaneous progress in store expansion and operational quality, underscoring its robust business resilience and long-term growth potential.

In terms of store development, DPC Dash continued to follow a disciplined "go broader, go deeper" expansion strategy, strategically "deepening" penetration in existing cities to enhance market share and "broadening" its reach into new markets. According to DPC Dash's First Quarter 2026 Investor Fact Sheet ("Investor Fact Sheet"), as of March 31, 2026, DPC Dash's total store count reached 1,462 stores across 72 cities, representing a net increase of 147 stores and expansion into 12 new cities compared to the end of 2025. On January 24, DPC Dash opened its 1,405^th store in Sanya, Hainan Province, marking a symbolic milestone as the store count matched the company's stock ticker on the Hong Kong Stock Exchange (HKEX). As of March 31, the Company's net new stores, stores under construction, and stores signed represent 65% of the full-year 2026 store opening target, with the pace of expansion far exceeding expectations. Non-Tier 1 cities have become the Company's main growth engine, while Tier 1 cities continue to provide a resilient, high-quality revenue base with proven unit economics.

Newly opened stores in new markets continued to deliver strong performance. DPC Dash now holds all of the top 50 positions for first 30-day sales among Domino's network of more than 22,100 stores globally, fully demonstrating the enormous potential of the Chinese market and the Company's outstanding operational capabilities. In terms of store count, the Chinese Mainland market has remained the 3rd largest international market within Domino's Pizza's global system.

In terms of its Digital strategy, the Company has significantly broadened its consumer base while deepening its understanding of consumer preferences. In the first quarter of 2026, DPC Dash continued to drive product innovation, introducing new global flavors including the Year of the Horse New Year limited-edition Yak Beef Matsutake Ham Fortune Pizza, the classic upgraded Bolognaise Plus Pizza, the innovative Snowball Cheese Margherita Pizza, and the Quadruple Cheese Grand Slam Pizza catering to cheese lovers, while also iterating the product portfolio with two new rice and pasta dishes, offering customers greater choice and enhanced value. These new offerings resonated strongly with consumers, effectively supporting consumer preference and sales growth even in a soft consumption environment and highly competitive market.

In terms of marketing activities, the Company brought back the classic "Mega Week" promotion and extended the "Crazy Tuesday & Wednesday" offer through Thursday, further boosting customer visits and order volume via value-driven promotions. Meanwhile, the Company collaborated with the Dunhuang Museum to offer exclusive Chinese cultural and creative (C&C) products, integrating traditional cultural elements into the brand experience, further strengthening brand affinity and cultural identity.

The expansion of the Company's loyalty program validates the success of its digital strategy. As of March 31, 2026, the loyalty program membership exceeded 38.8 million, compared to 27.2 million in the same period of 2025. Over the past 12 months, 17.6 million new customers placed their first orders with Domino's Pizza China. The accumulated user data helps the Company to achieve personalized recommendations, precision marketing, and efficient operations, further enhancing user stickiness and repeat purchase rates.

With further strengthened brand equity and rising brand momentum, DPC Dash will continue to execute its 4D strategy, planning to add approximately 350 net new stores during the full year 2026 to further enhance market penetration.

DPC Dash has gained inclusion in major indices including the Hang Seng Composite Index and Stock Connect programs, demonstrating capital market recognition of the Company's development prospects. With its strong execution track record, attractive store economics, and operational efficiency, the Company continues to deliver robust performance in a dynamic and competitive environment, creating sustainable, long-term value for shareholders.

About DPC Dash – Domino's Pizza China

DPC Dash is Domino's Pizza's exclusive master franchisee in the Chinese mainland, the Hong Kong Special Administrative Region of China and the Macau Special Administrative Region of China. Domino's Pizza, Inc., DPC Dash's global franchisor, is one of the most widely-recognized global consumer brands and the world's largest pizza company. Led by a seasoned and visionary management team, DPC Dash is a market leader that differentiates from competitors with, among others, a continually innovated and localized pizza-focused menu, unique expertise and leadership in delivery, technology focus and scalable and replicable store economic model. As of March 31, 2026, DPC Dash operates 1,462 stores in 72 cities in the Chinese Mainland.

For more information, please visit: www.dpcdash.com  

For official company announcements, please visit: www.hkexnews.hk

Contacts

Investor Relations:
DPC Dash Ltd
IR@dominos.com.cn

The maiden program comprises four initial diamond drill holes targeting sheared carbonatite-hosted REE mineralization and will test the depth and lateral continuity of mineralization along 900m of strike, where previous surface sampling returned results of up to 12.1% TREO.

El Campo is strategically located approximately four miles southeast of MP Materials' Mountain Pass REE Mine, a globally significant REE producer. Additional details are available here: https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-03076930-6A1319789&v=undefined.

"Our commencement of drilling at El Campo marks a significant step in advancing the broader rare earth potential of the Mojave Project," said Ian Stockton, Locksley Resources Technical Director. "The grade of surface mineralization identified to date provides a strong foundation, and this program will deliver the first subsurface data to assess continuity and inform the project's development potential."

The company is actively advancing the Mojave Project in California, targeting rare earth elements (REEs) and antimony. Locksley is executing a mine-to-market strategy for antimony, aimed at reestablishing domestic supply chains for critical materials, underpinned by strategic downstream technology partnerships with leading U.S. research institutions and industry partners. This targeted approach, combined with resource development with innovative processing and separation technologies, positions Locksley to play a role in advancing U.S. critical materials independence.

Contact: Beverly Jedynak, beverly.jedynak@viriathus.com, 312-943-1123; 773-350-5793 (cell)

Media, investors and analysts are invited to a simultaneous video webcast and telephone conference on the same day following the release of the results, starting at 09.00 CEST where Yannick Fierling, President and CEO, together with Therese Friberg, CFO, will present the report.

Information on how to join the video webcast and telephone conference is available HERE.

Slides used in the presentation and report will be available at the Group's website, www.electroluxgroup.com/ir.

CONTACT:

For more information:

Ann-Sofi Jönsson, Head of Investor Relations & Sustainability Reporting, ann-sofi.jonsson@electrolux.com,  +46 73 025 1005
Maria Åkerhielm, Investor Relations Manager, maria.akerhielm@electrolux.com, +46 70 796 3856
Henry Sjölin, Investor Relations Manager, henry.sjolin@electrolux.com, +46 76 863 51 85

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/electrolux-group/r/invitation-to-presentation-of-electrolux-group-q1-report,c4332186

The following files are available for download:

Breakout Financial Performance

Marvion reported revenue of US$3.47 million, representing a 100%+ year-over-year increase, alongside net income of US$345,083, reversing a prior-year loss and signaling a clear inflection point in the Company's growth trajectory.

This milestone positions Marvion among a growing class of emerging logistics platforms transitioning into scalable and profitable operations.

Entering a Scalable Growth Phase

Driven by increasing demand for logistics and warehousing solutions, Marvion is now entering into a scalable expansion phase, supported by:

• Growing enterprise customer demands
• Strengthened operational capabilities
• Expanding service offerings across logistics and supply chain

High-Visibility Recurring Revenue Model

A key highlight of 2025 is the successful rollout of a long-term solar energy income stream, generating stable quarterly revenue through 2033.

This recurring component introduces predictability and valuation support, enhancing Marvion's long-term financial profile.

Strategic Positioning for Growth and Capital Markets

With improving fundamentals, Marvion is actively:

• Exploring strategic partnerships and acquisitions
• Expanding its logistics footprint
• Strengthening its capital structure

The Company believes these initiatives could unlock significant shareholder value and improve its positioning in the public markets.

Management Commentary

"Our 2025 results represent a transformational milestone," said CEO of Marvion Inc.
"We are no longer in a restructuring phase — we are now in a growth phase."

"We believe Marvion is significantly undervalued relative to its growth trajectory, and we are focusing on closing that gap through execution and market engagement."

Outlook and Catalysts

Looking forward, key potential catalysts include:

• Revenue scale-up in logistics operations
• Expansion of recurring income streams
• Strategic investments or acquisitions
• Increase investor awareness and market visibility

Marvion is entering 2026 with strong momentum and a clear path towards sustained growth.

About Marvion Inc.

Marvion Inc. (OTCQB: MVNC) is a Nevada-incorporated holding company with principal offices in Hong Kong, focused on providing logistics, warehousing, fulfillment, and integrated supply chain services through its subsidiaries. The Company's diversified operations enable it to serve a broad range of client needs, and its business model is centered on both organic growth and strategic resource deployment. Marvion's common stock is quoted on the OTCQB Venture Market under the ticker MVNC.

For more information, please contact:
Marvion Inc.
Email: ir@unitedksk.com 
Website: www.unitedksk.com 

Upon the effectiveness of the reverse share split, every 150 shares of the Company's issued and outstanding Ordinary Shares, par value US$0.001 per share, will automatically be converted into one issued and outstanding Ordinary Share, par value US$0.15 per share. No fractional shares will be issued as a result of the reverse share split. Instead, any fractional shares that would have resulted from the split will be rounded up to the nearest whole share. The reverse share split affects all shareholders uniformly and will not alter any shareholder's percentage interest in the Company's outstanding Ordinary Shares, except for adjustments that may result from the treatment of fractional shares.

The reverse share split at a ratio of 1-for-150 shares was approved by the Company's board of directors and its shareholders. The Company is to file a Fifth Amended and Restated Memorandum and Articles of Association with the Cayman Islands Registrar of Companies effective April 7, 2026.

About Ridgetech, Inc.

Ridgetech, Inc. ("Ridgetech" or the "Company"), is a growing online and offline wholesale distributor of pharmaceutical and other healthcare products in China. Ridgetech actively trades on popular online distribution platforms nationwide and has its own online distribution platform. The Company believes that trading on these platforms offers greater opportunities to distribute pharmaceutical products nationwide. For more information about the Company, please visit www.ridgetch.com. The Company routinely posts important information on its website.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. These forward-looking statements include, but are not limited to, statements concerning the expected benefits from the cooperation arrangements with premier pharmaceutical companies and the investment in its proprietary digital customer operations platform. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to," or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Factors that could cause actual results or events to differ materially from those reflected in the Company's forward-looking statements including risks related to the Company's ability to satisfy applicable procurement conditions, changes in market demand, the Company's ability to successfully implement and promote its digital platform, and those other risks described in the Company's most recent registration statement, most recent annual report on Form 20-F and in its other filings with the U.S. Securities and Exchange Commission.

For more information, please contact:

Company Contact: 

Frank Zhao
Interim Chief Executive Officer and Chief Financial Officer
+86-571-88077108
frank.zhao@ridgetch.com

Investor Relations Contact:

Tina Xiao
Ascent Investor Relations LLC
+1-646-932-7242
investors@ascent-ir.com

Our Ordinary Shares will begin trading on a reverse share split-adjusted basis at the opening of The Nasdaq Capital Market ("Nasdaq") on April 6, 2026. Following the reverse share split, the Ordinary Shares will continue to trade on Nasdaq under the symbol "WNW" with the new CUSIP number, G9604C131. The reverse share split is expected to lead the Company's Ordinary Shares to trade at approximately 100 times the price per share at which it trades prior to the effectiveness of the reverse share split. The Company, however, cannot assure that the price of its Ordinary Shares after the reverse split will reflect the 1-for-100 reverse split ratio, that the price per share following the effective time of the reverse split will be maintained for any period of time, or that the price will remain above the pre-split trading price.

No fractional shares will be issued in connection with the reverse share split and all such fractional interests will be rounded up to the nearest whole number of Ordinary Shares.

The reverse share split will reduce the number of issued and outstanding shares of the Company's Ordinary Shares from 133,042,533 to approximately 1,330,426, subject to any adjustments resulting from the treatment of the fractional shares.

On March 17, 2026, the board of directors of the Company approved the reverse share split of the Ordinary Shares, at a ratio of 1-for-100.

TranShare Corporation is acting as the exchange agent and paying agent for the reverse share split. Shareholders holding their shares in book-entry form or in brokerage accounts need not take any action in connection with the reverse share split.

TranShare Corporation will provide instructions to any shareholders with certificates regarding the process in connection with the exchange of pre-reverse share split share certificates for ownership in book-entry form or share certificates on a post-reverse share split basis. Shareholders are encouraged to contact their bank, broker or custodian with any procedural questions.

About Meiwu Technology Company Limited

Meiwu Technology Company Limited is a British Virgin Islands company incorporated on December 4, 2018. Meiwu implemented a strategic transition of its business from online sales of selected high-quality food products and short message service to the skincare industry, and currently engages in the sale of the functional skincare products through Xiamen Chunshang Health Technology Co., Ltd. ("Chunshang Xiamen"), an indirect wholly owned subsidiary of Meiwu in China.

Safe Harbor Statement

Certain statements made in this release are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, are: the ability to manage growth; ability to identify and integrate other future acquisitions; ability to obtain additional financing in the future to fund capital expenditures; fluctuations in general economic and business conditions; costs or other factors adversely affecting our profitability; litigation involving patents, intellectual property, and other matters; potential changes in the legislative and regulatory environment; a pandemic or epidemic. The forward-looking statements contained in this release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission, which are available for review at www.sec.gov. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Such information speaks only as of the date of this release.

Contact
Meiwu Technology Company Limited
Zhichao Yang
Email: meiwuBS@usmeiwu.com

MONTREAL, April 1, 2026 /PRNewswire/ -- April 1, 2026 – Sydney, Australia

HIGHLIGHTS

• ESIA Submission: PMET Resources ("PMET" or the "Company") has submitted its Environmental and Social Impact Assessment (ESIA) for the Shaakichiuwaanaan CV5 Lithium Project, marking the most significant milestone in the Project's permitting journey to date. The project is subject to both a provincial and federal impact assessment, both of which have been submitted for review by respective authorities.
• Technical Foundation: The ESIA, together with the Feasibility Study released in October 2025, provides the comprehensive data required for government review of the Shaakichiuwaanaan Lithium Project. The ESIA submission marks the culmination of over four years of rigorous baseline data collection, technical evaluations, and extensive engagement with the Cree communities, local stakeholders, and government partners across all regulatory levels.
• The ESIA encompasses a comprehensive multidisciplinary analysis covering:
  • Environmental Baseline Studies: air quality, water resources, terrestrial and aquatic ecosystems, soil and geology.
  • Indigenous consultation and engagement: extensive dialogue with the Cree Nation, cultural heritage and traditional land use.
  • Socio and economic assessment: impacts on employment, community infrastructure and supply chain benefits.
  • Cumulative Effects assessment: assessment of combined impacts with other projects in the region.
  • Climate and Greenhouse Gas Considerations: The climate resilience and accounting of total greenhouse gas emissions from the project is included.
  • Impact mitigation and management: detailed strategies to minimize environmental and social effects

Grace Barrasso, PMET EVP of ESG and Corporate Affairs, commented: "The submission of this ESIA represents the culmination of years of rigorous scientific field work and meaningful dialogue with our Cree partners. Our goal is to develop Shaakichiuwaanaan as a model for sustainable critical mineral extraction in North America, ensuring that the environmental and social values of the Eeyou Istchee are protected while contributing to the global energy transition."

Ken Brinsden, PMET CEO and President, stated: "Moving from discovery to a formal ESIA submission and a completed Feasibility Study in roughly four years is a testament to the quality and scale of Shaakichiuwaanaan and the dedication of our team. Congratulations to our team and external advisors for their contributions to our premier project, creating a strong platform for our continuing engagement with the Cree and regulators as our project continues down the development pipeline."

PMET RESOURCES INC. (THE "COMPANY" OR "PMET") (TSX: PMET) (ASX: PMT) (OTCQX: PMETF) (FSE: R9GA) is pleased to announce the submission of the Environmental and Social Impact Assessment (ESIA) for its 100%-owned Shaakichiuwaanaan Lithium Project, located in the Eeyou Istchee James Bay region of Quebec.

The ESIA is a critical regulatory requirement under Section 22 of the James Bay and Northern Quebec Agreement (JBNQA). Concurrently with the provincial submission, PMET will also be submitting the ESIA to the federal Impact Assessment Agency of Canada (IAAC). THESE SUBMISSIONS, alongside the Positive CV5 Lithium-Only Feasibility Study delivered in late 2025, forms the dual pillars of the government's mine authorization process. Together, these documents detail the technical viability, environmental safeguards, and social integration of the proposed hybrid open-pit and underground mine.

LOOKING AHEAD

Following submission of the ESIA, the Federal government will initiate a public review period to invite comments from communities, regulators and project stakeholders. The report will be available on the Shaakichiuwaaan Mining Project Page published on the Canadian Impact Assessment Registry at: https://iaac-aeic.gc.ca and Québec portals.

The Company remains committed to maintaining a transparent and timely approval process, working closely with all levels of government and the Cree Nation to bring this world-class lithium asset into production over the coming years.

ABOUT PMET RESOURCES INC.

PMET Resources Inc. is a pegmatite critical mineral exploration and development company focused on advancing its district-scale 100%-owned Shaakichiuwaanaan Property located in the Eeyou Istchee James Bay region of Quebec, Canada, which is accessible year-round by all-season road and proximal to regional hydro-power infrastructure.

In late 2025, the Company announced a positive lithium-only Feasibility Study on the CV5 Pegmatite for the Shaakichiuwaanaan Property and declared a maiden Mineral Reserve of 84.3 Mt at 1.26% Li₂O (Probable)¹. The study outlines the potential for a competitive and globally significant high-grade lithium project targeting up to ~800 ktpa spodumene concentrate using a simple Dense Media Separation ("DMS") only process flowsheet. Further, the results highlight Shaakichiuwaanaan as a potential North American critical mineral powerhouse with significant opportunity for tantalum and caesium in addition to lithium.

The Project hosts a Consolidated Mineral Resource² totalling 108.0 Mt at 1.40% Li₂O and 166 ppm Ta₂O₅ (Indicated) and 33.4 Mt at 1.33% Li₂O and 155 ppm Ta₂O₅ (Inferred), and ranks as a top ten lithium pegmatite globally in size. Additionally, the Project hosts the world's largest pollucite-hosted caesium pegmatite Mineral Resource at the Rigel and Vega zones with 0.69 Mt at 4.40% Cs₂O (Indicated), and 1.70 Mt at 2.40% Cs₂O (Inferred).

For further information, please contact us at info@pmet.ca or by calling +1 (604) 279-8709, or visit www.pmet.ca. Please also refer to the Company's continuous disclosure filings, available under its profile at www.sedarplus.ca and www.asx.com.au, for available exploration data.

This news release has been approved by

"KEN BRINSDEN"

Kenneth Brinsden, President, CEO, & Managing Director

DISCLAIMER FOR FORWARD-LOOKING INFORMATION

This news release contains "forward-looking statements" and "forward-looking information" within the meaning of applicable securities laws.

All statements, other than statements of present or historical facts, are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and assumptions and accordingly, actual results could differ materially from those expressed or implied in such statements. You are hence cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are typically identified by words such as "plan", "development", "growth", "continued", "intentions", "expectations", "emerging", "evolving", "strategy", "opportunities", "anticipated", "potential", "additional", "on track", "prospects", "estimated", "enhancing", "strengthen", "target", "believes", "next steps", "looking ahead", "remains committed", "to bring", "coming years" or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. 

Forward-looking statements include, but are not limited to, statements concerning the permitting process for the Shaakichuwaanaan Project.

Forward-looking statements are based upon certain assumptions and other important factors that, if untrue, could cause actual results to be materially different from future results expressed or implied by such statements. There can be no assurance that forward-looking statements will prove to be accurate. Key assumptions upon which the Company's forward-looking information is based include, without limitation, the results of the Feasibility Study released in October 2025, the ability to complete an updated Feasibility Study for the CV5 Pegmatite with the addition of tantalum as a co-product, as well as a Preliminary Economic Assessment for the broader Project inclusive of lithium, caesium, and tantalum, that proposed exploration work on the Property and the results therefrom will continue as expected, the accuracy of reserve and resource estimates, the classification of resources and the assumptions on which the reserve and resource estimates are based, long-term demand for lithium (spodumene), tantalum (tantalite), and caesium (pollucite) supply, and that exploration and development results continue to support management's current plans for the Property's development.

Forward-looking statements are also subject to risks and uncertainties facing the Company's business, any of which could have a material adverse effect on the Company's business, financial condition, results of operations and growth prospects. Readers should review the detailed risk discussion in the Company's most recent Annual Information Form filed on SEDAR+, for a fuller understanding of the risks and uncertainties that affect the Company's business and operations.

Although the Company believes its expectations are based upon reasonable assumptions and has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking information will prove to be accurate. If any of the risks or uncertainties mentioned above, which are not exhaustive, materialize, actual results may vary materially from those anticipated in the forward-looking statements.

The forward-looking statements contained herein are made only as of the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable law. The Company qualifies all of its forward-looking statements by these cautionary statements.

COMPETENT PERSON STATEMENT (ASX LISTING RULES)

The information in this news release that relates to the Feasibility Study ("FS") for the Shaakichiuwaanaan Project, which was first reported by the Company in a market announcement titled "PMET Resources Delivers Positive CV5 Lithium-Only Feasibility Study for its Large-Scale Shaakichiuwaanaan Project" dated October 20, 2025 (Montreal time) is available on the Company's website at www.pmet.ca, on SEDAR+ at www.sedarplus.ca and on the ASX website at www.asx.com.au. The production target from the Feasibility Study referred to in this news release was reported by the Company in accordance with ASX Listing Rule 5.16 on the date of the original announcement. The Company confirms that, as of the date of this news release, all material assumptions and technical parameters underpinning the production target in the original announcement continue to apply and have not materially changed.

The Mineral Resource and Mineral Reserve Estimates in this release were first reported by the Company in accordance with ASX Listing Rule 5.8 in market announcements titled "World's Largest Pollucite-Hosted Caesium Pegmatite Deposit" dated July 20, 2025 (Montreal time) and "PMET Resources Delivers Positive CV5 Lithium-Only Feasibility Study for its Large-Scale Shaakichiuwaanaan Project" dated October 20, 2025 (Montreal time) and are available on the Company's website at www.pmet.ca, on SEDAR+ at www.sedarplus.ca and on the ASX website at www.asx.com.au. The Company confirms that, as of the date of this news release, it is not aware of any new information or data verified by the competent person that materially affects the information included in the relevant announcement and that all material assumptions and technical parameters underpinning the estimates in the relevant announcement continue to apply and have not materially changed. The Company confirms that, as at the date of this announcement, the form and context in which the competent person's findings are presented have not been materially modified from the original market announcement.

Olivier Caza-Lapointe, Head, Investor Relations, T: +1 (514) 913-5264, E: ocazalapointe@pmet.ca

Logo - https://mma.prnasia.com/media2/2947664/PMET_Resources_Inc__PMET_Resources_Submits_Environmental_and_Soc.jpg?p=medium600

Full Year 2025 Financial Highlights

• Revenue: $5,682,985 for fiscal year 2025, representing a 7.7% increase compared to approximately $5,274,495 for fiscal year 2024.
• Net Income: $1,905,145 for fiscal year 2025, representing a 28.1% increase from $1,487,630 for fiscal year 2024.
• Total Comprehensive Income: $2,031,627 for fiscal year 2025, compared to $1,489,302 in the prior year.
• Cash Position: Cash and cash equivalents were approximately $11.01 million as of December 31, 2025.

Business Overview

EUBG provides digital marketing consultancy services through its wholly-owned PRC subsidiary. The Company focuses on delivering marketing consulting and related services to enterprises in China, supporting brand development and customer acquisition through online and integrated service solutions.

Strategic Outlook

EUBG continues to focus on enhancing its core consulting capabilities while improving operational efficiency and service quality. The Company is also actively evaluating strategic opportunities to expand its business scope, including potential initiatives in fintech and related service areas.

In addition, on February 25, 2026, the Company effected a 1-for-10 reverse stock split, further aligning its capital structure with long-term strategic objectives.

Management Commentary

Mr. Guolin Tao, CEO of EUBG, stated:

"Our performance in 2025 reflects steady growth in our core business and continued improvements in operational efficiency.

We remain committed to optimizing our service offerings and strengthening our market position through disciplined execution and strategic expansion initiatives.

Looking ahead, we will continue to enhance our consulting capabilities while exploring new growth opportunities to support sustainable long-term development."

About Entrepreneur Universe Bright Group

Entrepreneur Universe Bright Group is a Nevada holding company that conducts its operations through its wholly-owned subsidiaries in Hong Kong and mainland China. The Company primarily engages in consulting, sourcing, and marketing services in China with support from its Hong Kong subsidiary.

For more information, please visit: www.eubggroup.com

Safe Harbor Statement

This press release contains projections and "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995 related to the Company's business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are not historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate," or similar expressions that do not relate solely to historical matters, it is making forward-looking statements.

Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially from those discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; future business development; financial condition and results of operations; product and service demand and acceptance; competition and pricing pressures; changes in technology; government regulations; fluctuations in economic and business conditions in China; and assumptions underlying or related to any of the foregoing and other risks contained in the Company's filings with the SEC. Investors are cautioned not to place undue reliance on any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect subsequent events or circumstances.

Dear shareholders,

Today, I would like to have an open and honest conversation with our shareholders, reflecting on Fosun's journey in 2025, sharing our thoughts, and outlining where we are heading next.

In 2025, the Company recorded a loss attributable to owners of the parent of RMB 23.4 billion. It should be noted that this loss does not reflect a deterioration in the Company's operating fundamentals. Instead, it was primarily attributable to the Board's prudent decision to recognize non-cash impairment provisions on certain projects arising from the Company's past development; it also involved impairment provisions on goodwill and intangible assets of certain non-core business segments. These provisions will not affect the Company's day-to-day operations, cash flow or business activities. Our core businesses such as pharmaceuticals and insurance continue to demonstrate steady growth.

A loss is never desirable. Such a result is also unprecedented in Fosun's more than thirty years of development. Although the loss is mainly non-cash items, we missed our profit expectations. As the Company's Chairman and Founder, I would like to express my sincere apologies to all shareholders and partners who care about Fosun's development. Over the years, Fosun has been bold in exploring and experimenting. We have had our share of successes and some missteps, each coming with valuable lessons learned. In recent years, China's real estate industry has undergone macro-structural adjustments. Although real estate accounts for a small portion of Fosun's business, it is natural for the market and investors to ask: Have Fosun's real estate projects not faced challenges and pressures, have all our past investments performed without setbacks? Of course, the answer is no. In hindsight, under the current market conditions, some of the projects we invested in years ago are now valued differently from what we expected at the time of investment. Accordingly, the Board has taken a prudent decision to complete this asset impairment, allowing Fosun to focus its resources and efforts more effectively on core, high‑growth areas. At a time when the global economy is generating opportunities amid volatility and China's innovation-driven industries are gaining growth momentum, deepening our strategic focus now allows us to optimize our asset structure and helps us secure a stronger position in key sectors, positioning Fosun as a leaner, healthier, and more sustainable company.

In terms of operating fundamentals, Fosun recorded operating revenue of RMB173.4 billion in 2025, with overseas revenue accounting for 54.7% of the total. Net cash flow from operating activities remained positive, average cost of debt continued to improve, and credit rating agencies such as S&P maintained stable ratings. Meanwhile, our financing capacity remained strong and our funding channels open. Our high-quality and resilient assets position us well for future growth. The total revenue of the four core enterprises - Fosun Pharma, Yuyuan, Fosun Portugal Insurance and FTG - reached RMB 128.2 billion, accounting for 74% of the Group's total revenue, a year-on-year increase of 3 percentage points.

It is precisely this strong foundation, together with the continued support of our partners, that gives us the confidence and determination to "repairing the roof on a sunny day". This is the moment to shed historical burdens and pursue predictable, sustainable growth. We must strengthen our core businesses with greater focus and depth to achieve steadier, longer-term growth in the next phase.

Smart innovation and integrated innovation driven by innovation

Going global or going obsolete. Innovation works the same way. Innovate or be left behind. In this fast-paced era, we must remain committed to innovation, especially smart innovation. We must collaborate with others and learn from others. Innovation is not a solo endeavor, nor should it happen behind closed doors. That is why I have always emphasized "integrated innovation", building an innovation system with two core capabilities, "global research and development ("R&D") + global business development ("BD")".

In 2026, we will place even greater emphasis on innovation as our top priority, steering Fosun's transition from scale expansion toward quality enhancement, and from resource integration toward value creation.

We have always been committed to pharmaceutical innovation. As early as 2006, we began systematically building our pharmaceutical R&D capabilities, starting with high-value generic drugs and steadily advancing toward true innovation. In 2019, China's first biosimilar, HANLIKANG, received marketing approval, marking a major milestone. By 2023, Henlius had turned profitable, 17 years since we first embarked on this journey. Throughout the years, we have remained true to our original aspiration of "always striving to heal", and to our vision of helping people live to 121.

Looking back, we now have nearly 70 major pipeline projects on innovative drugs (calculated by indications), forming a tiered pipeline spanning "early-stage frontier research, mid-stage proof-of-concept, and late-stage clinical expansion". By continuously strengthening our innovation pipeline, we are accelerating the clinical translation and commercialization of innovative technologies and products. We currently have multiple blockbuster candidates in the pipeline.

Take Henlius as an example. It has already achieved dual-engine growth driven by both biosimilars and innovative drugs. Core products like HANLIKANG, HANQUYOU, and HANSIZHUANG have been approved for marketing in around 60 countries and regions worldwide. HANSIZHUANG has not only been launched in Europe, but has also been included in public reimbursement programs in seven countries, including Germany, Italy, and Spain. Fosun Pharma has progressively established a high-value pipeline portfolio focusing on core therapeutic areas including oncology (solid tumors, hematologic tumors), immunology, inflammation and neurodegenerative diseases. Moving forward, Fosun Pharma will continue to strengthen its core technology platforms encompassing antibodies, antibody-drug conjugate ("ADC"), small molecules and cell therapy, while actively expanding its presence in cutting-edge technologies such as radiopharmaceuticals and small nucleic acids, enhancing our R&D ecosystem. We are currently planning the spin-off and separate listing in Hong Kong for our vaccine platform, Fosun Adgenvax, aiming to leverage the capital market to improve its governance standards and sustainable development capabilities, thereby creating greater value for our shareholders.

In terms of artificial intelligence ("AI"), I have been following it closely over the past few years. However, we are not chasing the concept of large language models. For us, AI is not about appearances; it is about solving real problems. And we have already made tangible progress. Fosun Pharma's PharmAID^® Pharmaceutical Intelligence Platform now delivers T+1 data updates, accelerating drug R&D; FTG's AI G.O intelligent system makes tourism services more personalized. More importantly, AI is now deeply integrated into Fosun's daily operations to enhance decision-making efficiency and optimize operating costs. Going forward, we will continue to invest in AI to make it a truly practical operational tool, maximizing efficiency across the Group.

Fosun always embraces ecosystem thinking. We believe innovation thrives through collaboration, not solo efforts. Take Fosun United Health Insurance's "Ruixingbao" as an example: through our "insurance + industry" model, we integrate insurance services with premier medical resources such as Ruijin Hospital, along with pharmaceutical, healthcare, and consumer offerings. This makes insurance the connector, linking our ecosystem to families and turning ecosystem advantages into product competitiveness. Looking ahead, we will launch more products that bring together ecosystem resources to meet the needs of customers and serve more families. This is where our deepest sense of fulfillment comes from.

Innovation keeps us young. Fosun was founded 34 years ago, but we still approach every day as if it were day one, with a constant hunger for new technologies, new opportunities, and new possibilities.

Deepening global operations: from business presence to product and brand globalization

Fosun's globalization journey began in 2007 with our listing on the Hong Kong Stock Exchange. At that time, we started building our overseas business presence through equity and debt investments. Over the years, our globalization journey has evolved through three phases: from "China Expertise + Global Capability", to "Combining China's Growth Momentum with Global Resources" and then to "Combining Global Resources with China's Capabilities". This progression is not merely a matter of wording; it reflects the continuous evolution of Fosun's globalization capabilities. What began as establishing business presence later evolved into capability building, and today, we are truly integrating operations and investments on a global scale.

Regarding the insurance sector, our acquisition of Fosun Insurance Portugal in 2014 has evolved far beyond the initial "buyout". While continuing to deepen its presence in the local market, we have also empowered it to expand beyond Portugal into Europe, Latin America, and Africa. In 2025, Fosun Insurance Portugal delivered a profit attributable to owners of the parent of approximately EUR201 million, with international operations accounting for over 30% of its consolidated businesses. Building on years of development, the two domestic insurance companies have also reached a new stage of profitable and high‑quality growth. In 2025, Fosun United Health Insurance reported insurance revenue of RMB7.84 billion, representing a year-on-year increase of 50.1%, with net profit for the year reaching RMB139 million, marking five consecutive years of profitability. Pramerica Fosun Life Insurance achieved RMB13.28 billion in scale premium, representing a year-on-year increase of 41.6%, while net profit surged 492% year-on-year to RMB650 million. While continuing to develop our core insurance business, we also recognize that in the current landscape, a number of existing assets with long‑term value potential are ready to be revitalized through transformation, upgrading, and strong operational management. Some of these assets not only generate stable cash flows and provide a foundation for long‑term returns, but also have clearly defined risk boundaries, offering useful reference points for long‑term capital allocation, including by insurance institutions.

Regarding the consumer sector, Yuyuan has accelerated product innovation and channel optimization. Its catering brand, Songhelou, opened its first overseas branch in London, the United Kingdom, while jewelry brand, Laomiao, opened its first overseas store in Kuala Lumpur, Malaysia. FTG, with Club Med as its core, has firmly strengthened lean management. During the core six-day Chinese New Year holiday period, Club Med's five all-inclusive resorts in China recorded an average occupancy rate of 90%. During the nine-day Chinese New Year holiday period, Atlantis Sanya recorded business volume of over RMB124 million, representing a year-on-year increase of 20% and achieving its best Chinese New Year performance on record.

In the Intelligent Manufacturing segment, Hainan Mining, rooted in Hainan and expanding globally, focuses on the most upstream exploration, mining, processing and sales of strategic mineral resources. It has built a diversified global resource footprint spanning China, Southeast Asia, West Africa, and the Middle East, with mineral products covering various strategic mineral resources such as iron ore, lithium, oil, and natural gas. In 2025, supported by the steady advancement of overseas resource projects, the share of overseas assets rose to 46.04%.

More importantly, our globalization strategy has evolved from "acquiring globally" to the 3.0 era of "earning globally". Our products, brands, and services are now reaching customers around the world. The proportion of overseas revenue of Henlius' products such as HANQUYOU and HANSIZHUANG continues to rise. Our nationally recognized intangible cultural heritage event, the Yuyuan Lantern Festival, along with time‑honored Chinese brands such as Laomiao, Songhelou, and Nanxiang Steamed Buns Restaurant, and Shede baijiu are also gaining growing recognition among families in overseas markets. For Fosun, globalization is not a choice, it is inevitable. We have already proven that this path works, and we will go even further in the years ahead.

Staying true to our original aspiration and adhering to long-termism

Fosun has always stayed true to its original aspiration: to do the right things, the difficult things and the things that take time to develop.

We have always said that we must learn to move with the cycles while staying grounded in intrinsic value. Fluctuations in corporate value often stem from three overlapping cycles: the industry cycle, the capital market cycle, and the company's own cycle. The first two cycles are largely beyond our control. All we can do is to remain patient and wait them out. What we can change, however, is our own cycle. How well we manage our businesses and whether we have the right people in place are precisely the things we can improve through day‑to‑day operations and management. But patience takes time, and it also requires long-term capital. What kind of company does Fosun want to be? We need sufficient long-term capital to support our growth and the resilience to navigate through cycles. Just as importantly, we need the ability to continuously transform and strengthen our businesses.

This is why we must always remain committed to long-termism. Long-termism is not simply about "waiting". It is about continuously enhancing the Company's value in the process. As we wait for the industry cycle and capital markets cycle to turn, we must first manage our own cycle well. This is the key to Fosun's ability to navigate through cycles, and it is the long-termism we have upheld for over thirty years and will continue to uphold.

Doing good through business has always been part of our original aspiration. Over the past three decades, no matter the cycle, I have firmly believed that the value a company creates comes not only from its products, but also from the lives it touches and the social responsibilities it carries. Fosun Pharma has long worked to expand global access to artemisinin‑based medicines. In addition to improving drug quality through technology innovation, we have collaborated with many global charitable organizations to build local supply networks in Africa, ensuring that children in less developed regions can afford and access life-saving medicines. Bridging the "last mile" is never easy, but every additional bottle of medicine could mean one more child saved. Take HANSIZHUANG as another example, traditional chemotherapy for gastric cancer often brings severe side effects, causing many patients to abandon treatment. After 15 years of R&D, we brought HANSIZHUANG to market, ushering in a chemotherapy-free era in gastric cancer treatment. It not only allows patients to live longer, but also to live with dignity, and in some cases, even to offer hope for a cure. Our long-standing Rural Doctors Program addresses the reality that "minor illnesses often turn into serious illnesses" in remote areas. Operating in 78 key rural revitalization counties across 16 provinces, the Rural Doctors Program has supported 25,000 rural doctors, benefiting 3 million grassroots families across China's central and western regions. This is not a one‑off assistance effort, but a long‑term commitment to protecting the elderly and children who still live in rural areas and cannot easily travel to big cities.

Fosun has integrated ESG principles into every aspect of its development. We are actively promoting carbon neutrality and continuously investing in green energy, energy conservation and emission reduction, and eco-friendly materials. We are committed to compliant operations and we continue to strengthen transparency in our disclosures, so shareholders and the society can better understand Fosun. For us, an outstanding company is one that delivers commercial value while also taking responsibility for society and the environment.

To our shareholders and friends, "repairing the roof on a sunny day" requires both courage and resolve. Our core businesses remain solid, our liquidity position is robust, and our banking relationships remain stable. That is what gives us the confidence to move forward with this round of provisions. As we recently announced, our major shareholder and management team plan to increase their holdings in the shares of the Company and we will also proceed with a share buyback program. With our core businesses continuing to grow and our strategic plans firmly on track, we are confident in our ability to support a return of the share price to fair value and better protect the long-term interests of our shareholders. Our medium‑term financial goals are as follows: we strive to gradually restore annual profit to the RMB10 billion level; at the group level, we aim to generate RMB60 billion in cash returns, reduce total debt to below RMB60 billion, and strive to achieve an investment‑grade rating.

I would like to thank our shareholders and friends for your trust, understanding, and steadfast support over the years. Over the past more than thirty years, Fosun has come a long way and weathered many challenges. Looking back, none of it was in vain. We are grateful to this era for the opportunities it has given us, and we are equally grateful for the lessons we have paid for, which have made us more clear-eyed and more resolute.

For Fosun's future, we do not seek short-term gains; we seek to build a foundation for lasting success. We look forward to working side by side with all of you and, with prudent and pragmatic resolve and action, embracing a future in which Fosun renews itself through transformation and gathers strength for new growth.

Guo Guangchang

30 March 2026

During the Reporting Period, the Group's total revenue reached RMB173.43 billion, and adjusted industrial operation profit amounted to RMB4 billion. The four core subsidiaries generated RMB128.2 billion in revenue, accounting for 74% of the Group's total revenue. Among them, Fosun Pharma, a core subsidiary in the Health segment, achieved a net profit attributable to shareholders of the parent of RMB3.371 billion, representing a year-on-year increase of 21.69%; Fosun Insurance Portugal, a core subsidiary in the Wealth segment, reported a net profit attributable to owners of the parent of EUR201 million, up 15.8% year on year.

During the Reporting Period, the Group's investment in technology innovation reached RMB7.8 billion, and 16 indications of 7 innovative drugs were approved for marketing in China and overseas markets. In addition, nearly 40 innovative drug clinical trials were approved by regulatory authorities in China, the United States and Europe, while multiple core products entered key clinical phases, laying a solid pipeline foundation for subsequent commercial growth.

During the Reporting Period, the Group's overseas revenue reached RMB94.86 billion, accounting for 54.7% of total revenue, representing a year-on-year increase of 5.4 percentage points. For innovative drugs, total upfront payments from licensing-out and co-development for the year exceeded USD260 million, with total potential milestone payments exceeding USD4 billion. Club Med once again achieved record-high performance, while insurance companies in China and overseas delivered broad-based growth.

Fosun has continued to advance its strategy of "streamlining operations and strengthening the business, focusing on core businesses". During the Reporting Period, pursuant to the principle of prudence, Fosun made non-cash impairment provisions and value revaluations on certain real estate projects with impairment indicators and goodwill and intangible assets of certain non-core business segments, resulting in a book loss of RMB23.4 billion for the year, of which real estate-related impairment accounted for approximately 55%, while impairment of non-core assets accounted for approximately 45%. These provisions do not affect the Company's overall operations and cash flow.

In his letter to shareholders, Guo Guangchang, Chairman of Fosun International, stated: "Some of the projects we invested in years ago are now indeed valued differently under current market conditions from what we expected at the time of investment. Accordingly, the Board has prudently chosen to complete this asset impairment, allowing Fosun to better concentrate its resources and efforts on high-growth core sectors. As the global economy presents opportunities amid fluctuations and China's innovation industry gains momentum, deepening our strategic focus now allows us not only to optimize our asset structure, but also to seize industry opportunities, positioning Fosun as a leaner, healthier, and more sustainable company."

At the same time, Fosun has maintained a healthy financial position, with ample cash reserves, a solid net asset base, and positive net cash inflow from operating activities. As at the end of the Reporting Period, total debt to total capital ratio was 57%; in addition to cash, bank balances and term deposits of RMB61.1 billion, unutilized banking facilities amounted to RMB144.6 billion. A healthy debt ratio and ample funds not only strengthen the Company's risk resilience, but also enhance its capacity to seize opportunities. International rating agency S&P has affirmed the outlook for Fosun International's credit rating as "Stable".

"It is precisely this strong foundation, together with the continued support of our partners, that gives us the confidence and determination to 'repair the roof while the sun is shining' — to shed burdens at this stage and pursue predictable, sustainable growth for the future. We must strengthen our core businesses with greater focus and depth. This is the path for Fosun to move more steadily and go further in the next phase," said Guo Guangchang.

Fosun also announced its medium-term financial targets: to strive to gradually restore annual profit to around RMB10 billion; to target the recovery of RMB60 billion in cash at the Group level, reduce total Group-level debt to below RMB60 billion, and work to achieve an "investment-grade" rating.

In terms of further enhancing shareholder returns, in addition to share purchases by the controlling shareholder and management, as well as the Company's continued share buybacks, Fosun announced that it plans to increase its target dividend payout ratio for the 2026 financial year from the current 20% to 35%, and is committed to further raising the payout ratio over time. Based on the Company's accumulated distributable profits, dividends for the 2026 financial year are expected to be no less than HKD1.5 billion.

"For the future, Fosun will not pursue short-term gains; instead, we will build a solid foundation for enduring growth," said Guo Guangchang.

Getinge's 2025 Annual Report summarizes the year's performance, both financially and in sustainability, and provides an overview of the company's strategy, targets, and governance. The medtech company's net sales in 2025 amounted to SEK 35 billion, with organic growth across all business areas. Despite combined headwinds from currency effects and tariffs exceeding SEK 1 billion, the company delivered an unchanged adjusted EBITA margin for the full year, confirming a robust business model and increased operational resilience.

"2025 was a year in which our strategy, global presence, and ways of working were truly tested - and proved their strength. Despite a more complex external environment, we delivered steady results, reached important regulatory milestones, and continued to strengthen our position in our prioritized markets," says Mattias Perjos, President and CEO at Getinge.

During the year, Getinge made significant progress in quality and regulatory compliance, including the reinstatement of the CE certificate for its intra-aortic ballon pump Cardiosave and several new MDR approvals. At the same time, several new products and solutions were launched within intensive care, surgical workflows, and life science, with a focus on productivity, patient safety, and sustainable use of resources.

Demand for more efficient and sustainable healthcare continues to be driven by demographic changes, resource constraints, and increasing pressure on healthcare systems. Getinge addresses this through a broad offering, close customer collaboration, and an increasing number of solutions that improve workflows and reduce environmental impact.

"Our long-term direction remains unchanged. With a focus on quality, innovation, and close customer partnerships, we continue to build on a strong foundation for profitable growth and long-term value creation," says Perjos.

Getinge has continued to strengthen its financial position with reduced net debt and strong equity ratio. The Board of Directors proposes a dividend of SEK 4.75 per share for the 2025 financial year.

Getinge's Annual Report for 2025, including the Sustainability statement, is available at https://www.getinge.com/.

Investor Relations:

David Kördel, Head of Investor Relations
Phone: +46 (0)10 335 0077
Email: david.kordel@getinge.com 

Media contact:

Caroline Örmgård, Head of Media Relations
Phone: +46 (0)10 335 0041
Email: caroline.ormgard@getinge.com

This information is information that Getinge AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 10.00 CET on March 26, 2026.

About Getinge

With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/getinge/r/getinge-publishes-annual-report-for-2025,c4327032

The following files are available for download:

The MSCI ESG ratings are an ESG assessment framework widely used by global investment institutions, and its rating results have become a key reference for evaluating a company's sustainability performance and long-term investment value. Fosun International's rating upgrade to AAA demonstrates that its overall management across environmental, social, and governance aspects has reached a leading level among global peers, particularly in maintaining a competitive edge in key areas such as responsible investment, business ethics, and clean technology opportunities.

Five years of sustained efforts: a leap from AA to AAA

Looking back at Fosun's journey in MSCI ESG ratings, each step reflects Fosun's steadfast commitment and continuous improvement in sustainability. In 2021, Fosun International's MSCI ESG rating was upgraded from A to AA, making it the only conglomerate in Greater China to receive an AA rating at that time. Since then, the Group has maintained its AA rating, steadily consolidating its leading position.

This rating upgrade from AA to AAA not only represents MSCI's strong recognition of Fosun International's ESG efforts over the past five years, but also marks the Group's leap from "good" to "excellent" in sustainability. This achievement reflects Fosun International's sustained efforts to deeply integrate ESG principles into its corporate strategy and daily operations, and to establish a top-down ESG governance structure and management system across the Group.

Establishing a long-term mechanism: fully linking ESG with performance

Fosun has remained true to its original aspirations of "Self-improvement, Teamwork, Performance, and Contribution to Society" and views sustainability as the core driver of its corporate development. The Group has established a top-down and long-term mechanism for ESG improvement and has included ESG management performance as an evaluation factor in the Executive Directors' performance assessment, with the evaluation scope further extended to the CEOs of the Group and the personnel in charge of each business group.

On the governance front, Fosun International has established an ESG Board Committee under the Board of Directors (the "Board"), chaired by an Independent Non-Executive Director, to assist the Board in guiding and overseeing ESG initiatives. At the management level, the Group has established an ESG Executive Committee to provide decision support for the implementation of ESG strategies. At the implementation level, the Group has set up an ESG Management Committee and an ESG Working Group to ensure the effective operation of ESG risk management and internal control system.

Honoring green commitments and leading climate action

Facing global climate change challenges, Fosun International actively responds to the national "dual carbon" goals. In 2021, the Group made a commitment to society – "strive to peak carbon emissions by 2028 and achieve carbon neutrality by 2050". The Group has established a Carbon Neutrality Committee and Working Group to drive the implementation and enforcement of carbon-neutral management across the Group. For three consecutive years, Fosun has also published its Climate Information Disclosures Report, aligning with the Task Force on Climate-Related Financial Disclosures (TCFD) recommendations and International Financial Reporting Standards S2 Climate-related Disclosures Requirements ("IFRS S2") to enhance the transparency of its climate actions.

Innovation-driven: empowering society with technology

Fosun International adheres to an innovation–driven strategy, driving its businesses to achieve innovative breakthroughs that broadly benefit patients worldwide. Henlius' independently developed HANSIZHUANG (serplulimab, European trade name: Hetronifly®), the world's first anti-PD-1 monoclonal antibody approved for first-line treatment of small cell lung cancer (SCLC), has been approved in Europe and multiple emerging markets for first-line treatment of extensive-stage SCLC (ES-SCLC), as well as in Indonesia and Thailand for squamous non-small cell lung cancer (sqNSCLC). It has also been included in public reimbursement systems in seven European Union (EU) countries, including Germany, Italy, and Spain. As of 2025, HANSIZHUANG has been approved in over 40 countries and regions worldwide, with continued progress in lung and gastrointestinal cancers, including the potential to set multiple new cancer treatment standards. Fosun Pharma has supplied over 440 million doses of its independently developed artesunate for injection, cumulatively treating over 88 million patients with severe malaria globally, continuously contributing the "China Solution" to the fight against malaria in Africa.

Upholding its original aspiration of "Contribution to Society" and actively giving back to society

As part of its commitment to corporate social responsibility, Fosun Foundation was established in 2012 and has been creating social value in areas such as global emergency relief, rural revitalization, health, education, culture and art, and youth development. Since its launch at the end of 2017, the Rural Doctors Program has covered 78 key rural revitalization counties in 16 provinces across China, supporting 25,000 rural doctors and benefiting 3 million grassroots families in central and western China. In 2024, the program was selected as one of the "20 Cases of Private Sector's Sustainable Development in China for 20 Years" by the United Nations Global Compact (UN Global Compact).

Continued recognition from international authoritative rating agencies

In addition to its MSCI ESG rating, Fosun International's sustainability performance has been widely recognized by multiple international authoritative institutions. To date, Fosun International has achieved an S&P Global Corporate Sustainability Assessment (CSA) score of 73, maintaining a leading position among global peers; has been included in S&P Global's Sustainability Yearbook 2026; has maintained an HSI ESG rating of AA- and has been included in the Hang Seng Corporate Sustainability Benchmark Index for six consecutive years; has retained a leading FTSE Russell ESG score of 4.2 and has been included in the FTSE4Good Index Series for the fifth consecutive time, achieving a full score of 5.0 in several areas, including Environmental Supply Chain, Anti-Corruption, Risk Management, Social Supply Chain, and Corporate Governance.

Looking ahead, Fosun International will continue to strengthen its industry focus, deepen its innovation and globalization strategies, and advance ESG initiatives with higher standards and stronger execution, remaining steadfast in its mission of "creating happier lives for families worldwide" and creating long-term value for its customers.

The offering is expected to close on or about March 25, 2026, subject to the satisfaction of customary closing conditions.

The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.

A.G.P./Alliance Global Partners is acting as the financial advisor for the offering.

The Class A ordinary shares (or Class A ordinary shares equivalents in lieu thereof) are being offered and sold pursuant to a prospectus supplement to be filed with the Securities and Exchange Commission ("SEC") in connection with a takedown from the Company's shelf registration statement on Form F-3 (File No. 333-291788), which was declared effective by the Securities and Exchange Commission ("SEC") on December 3, 2025. The offering is being made only by means of a prospectus supplement and accompanying prospectus which are a part of the effective registration statement. The warrants will be issued in a concurrent private placement. A prospectus supplement and the accompanying prospectus relating to the registered direct offering will be filed with the SEC and will be available on the SEC's website at www.sec.gov. Additionally, when available, electronic copies of the prospectus supplement and the accompanying prospectus may be obtained from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at prospectus@allianceg.com. The private placement of the warrants and the ordinary shares underlying the warrants offered to the institutional investor(s) will be made in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), and Regulation D promulgated thereunder. Accordingly, the securities issued in the concurrent private placement may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Paranovus Entertainment Technology Limited

Paranovus Entertainment Technology Ltd. focuses e-commerce and TikTok-related e-commerce solutions through its subsidiaries. In March 2025, the Company completed the acquisition of the controlling equity interests of Bomie Wookoo Inc., a New York company that offers e-commerce solutions. As part of its strategic transformation, Paranovus has exited its legacy businesses, including the e-commerce, internet information, and advertising businesses in September 2023 and ceased its automobile sales business in July 2024.

For more information on our latest innovations and developments, visit https://www.pavs.ai/.

Forward-Looking Statements

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; the Company's future acquisition opportunities; the Company's ability to identify any acquisition opportunities that fit with our business strategies; the Company's ability to consummate an attractive acquisition and realize the benefits of such transaction; product and service demand and acceptance; changes in technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the U.S. Securities and Exchange Commission, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

The Company intends to timely request a hearing before an independent Hearings Panel (the "Panel"). Notwithstanding, given that the Company traded below $0.10 for 10 consecutive business days, the hearing request will not stay the suspension of the Company's securities. During the pendency of the hearing, the Company expects that its securities will be eligible to be traded on the OTC Markets under the same ticker symbol "UOKA." There can be no assurance that the Panel will grant the Company's request for continued listing or otherwise provide relief from the suspension determination, and the ultimate outcome of the hearing process remains uncertain.

The Company is currently considering all options available to regain compliance with Nasdaq's listing requirements and return to good standing on Nasdaq, including a reverse stock split, which became effective on March 16, 2026, and will provide its shareholders with any material updates when they are available.

About MDJM LTD

MDJM LTD is a global culture innovation company focused on cultural IP development, animation production, international licensing, and cultural venue operations. The Company has been expanding its operations in the UK, where it is developing projects such as Fernie Castle in Scotland and the Robin Hill Property in England. These properties are being remodeled into multi-functional cultural venues that will feature fine dining, hospitality services, art exhibitions, and cultural exchange events. As part of its broader strategy, the Company is collaborating with select European animation studios to develop animated short films that blend Eastern themes with Western artistry. The Company aims to integrate Eastern philosophy with international artistic practices, creating a global cultural ecosystem built on storytelling and immersive experience. This initiative reflects the Company's commitment to furthering its global market expansion and enhancing its cultural business footprint. For more information regarding the Company, please visit https://www.ir-uoka.com/.

Forward-Looking Statements

This announcement contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's annual report on Form 20-F and its other filings with the U.S. Securities and Exchange Commission.

Investor Contact

Sherry Zheng
WAVECREST GROUP INC.
Phone: +1 718-213-7386
Email: sherry@wavecrestipo.com 

Pursuant to the LOI, the Acquisition's total consideration is estimated to range between US$37 million to US$40 million through a combination of cash and stock issuance. The Acquisition is subject to the negotiation and execution of definitive documentation, completion of due diligence, receipt of regulatory approvals, and necessary corporate approval, alongside other customary closing conditions.

This proposed Acquisition represents a pivotal strategic evolution for CHNR, advancing the Company's dual mandate to strengthen its core mining operations through AI and to build a scalable growth platform in cutting-edge AI and IoT technologies. CHNR plans to deploy HooRii's AI and IoT expertise to optimize mining workflows, enhance safety, and improve cost efficiency across CHNR's global assets, while leveraging HooRii's market-leading technology to expand into the high-growth Physica AI market, diversifying beyond traditional resources.

Since its founding in 2021, HooRii has been at the forefront of IoT technology. Supported by Feishang, HooRii is a world-leading company at the intersection of AI and IoT, determined to become a key force in connecting artificial intelligence with the physical world, driven by the mission to "Bring your AI to the real world." HooRii initially focused on advancing the development and commercialization of the Thread protocol, successfully launching a series of hardware and software products and solutions that provided robust technical support for millions of IoT devices and thousands of developers worldwide.

In 2026, as OpenClaw became the most popular project in GitHub's history, a wave of Personal AI Assistants swept the globe. HooRii seized this momentum to launch ClawStage, the first embodied personal AI built on the OpenClaw architecture. This landmark product received widespread acclaim within a month of its launch, gaining over ten million impressions and attracting more than ten thousand seed users. Since its inception, HooRii has secured multiple rounds of investment from renowned funds, including Plum Venture, Eminence Venture, and PreAngel Venture, with total financing exceeding $7 million USD.

"Today's announcement marks a watershed moment for CHNR," said, Wong Wah On Edward, Chief Executive Officer of CHNR. "As an experienced company in the traditional industries, we recognize that embracing AI is not merely an opportunity—it is a necessity. This proposed acquisition would accelerate our transformation, enabling us to apply HooRii's innovative technology to our core mining business while unlocking new revenue potential in the fast-growing physical AI ecosystem. We are committed to balancing the strength of our heritage with the agility of a tech-enabled future."

"HooRii's journey from a start-up to a leader in physical AI is a testament to our team's innovation and vision," said Albert Licheng Zhu, Chief Executive Officer of HooRii Technology. "Teaming up with CHNR will provide us with the financial strength, global reach, and operational scale to accelerate product development and market expansion. We are delighted to partner with CHNR to redefine the future of both AI&IOT and the resources industry."

Important Disclosure Regarding the LOI

The foregoing description of the LOI does not purport to be complete and are qualified in its entirety by reference to the full text of the agreement, which the Company plans to furnish as an exhibit on its current report on Form 6-K.

Investors are cautioned that the LOI is non-binding and serves only as a preliminary expression of intent. The Company provides no assurance that a definitive agreement will be executed or that the proposed acquisition will be consummated on the terms described, or at all. Furthermore, the Company can offer no guarantee regarding the timing of the potential closing, which remains subject to the satisfaction of various closing conditions.

About China Natural Resources, Inc.

China Natural Resources, Inc. (NASDAQ: CHNR) is currently a holding company that operates in exploration and mining business. The Company is engaged in the acquisition and exploitation of mining rights in Inner Mongolia, including exploring for lead, silver and other nonferrous metal, and is actively exploring business opportunities in the healthcare and other non-natural resource sectors. Committed to operational excellence, sustainability, and shareholder value, CHNR is advancing a strategic transformation to integrate AI and technology across its business.

About HooRii Technology Limited

HooRii is a Hong Kong-based Physical AI innovator specializing embodied personal AI built on the OpenClaw architecture. Supported by Feishang and many other venture capital funds, HooRii is dedicated to making AI accessible and intuitive for consumers and businesses worldwide.

Forward-Looking Statements

This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on the SEC's website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Other than as required under the applicable securities laws, the Company does not assume a duty to update these forward-looking statements.

MONTREAL, March 19, 2026 /PRNewswire/ -- March 19, 2026 – Sydney, Australia

Highlights

• Widest caesium drill intercept recorded to date at the newly discovered Helios Zone:
  • 4.9 m at 3.65%Cs₂O including 1.7 m at 6.14%Cs₂O (CV25-979).
  • 0.5 m at 6.28%Cs₂O (CV25-984).
• Strong caesium grades intersected in drill hole located outside the known mineralized zones at the CV13 Pegmatite, indicating the presence of a new mineralized lens north of the Vega Zone:
  • 2.3 m at 4.65% Cs₂O (CV25-999).
• A total of 57,024 m (245 holes) of drilling was completed in 2025, with results for lithium, caesium, and tantalum now reported for all drill holes:
  • This release reports results from 1,176 m (7 holes) of drilling completed at the CV13 Pegmatite.

Darren L. Smith, Executive Vice President Exploration, comments: "The results conclude reporting for all drill holes from the Company's highly successful 2025 drilling campaign at Shaakichiuwaanaan, which has delivered multiple significant new discoveries and further demonstrated the globally relevant scale, grade, and multi-commodity critical mineral potential of the Property. The team continues to execute at the highest levels, as exemplified in the Company's continued exploration success and development progress.

"Current work is focused on integrating the new datasets into the Company's exploration strategy and updated geological models, which will underpin the next round of exploration and an updated Feasibility Study at CV5 incorporating a tantalum co-product, as well as a Preliminary Economic Assessment for the broader Project covering lithium, caesium, and tantalum," added Mr. Smith.        

PMET Resources Inc. (the "Company" or "PMET") (TSX: PMET) (ASX: PMT) (OTCQX: PMETF) (FSE: R9GA) is pleased to report the final assay results from its 2025 drill campaign at the Company's wholly-owned Shaakichiuwaanaan Property (the "Property" or "Project"), located in the Eeyou Istchee James Bay region of Quebec. The reported drill holes targeted caesium mineralization at the CV13 Pegmatite.

In addition to being one of the largest lithium-tantalum pegmatite Mineral Resources¹ and lithium pegmatite Mineral Reserves² globally, the Property also hosts the world's largest in-situ pollucite-hosted caesium pegmatite Mineral Resource, comprising 0.69 Mt at 4.40% Cs₂O (Indicated) and 1.70 Mt at 2.40% Cs₂O (Inferred). The CV13 Pegmatite, which hosts the caesium Mineral Resource, is located ~3 km along trend from the CV5 Pegmatite, which is situated approximately 13 km south of the regional Trans-Taiga Road and powerline infrastructure corridor, and is accessible year-round by road.

Figure 1: 2025 drill hole results for caesium at the CV13 Pegmatite.

Core assay results for caesium for the remaining 1,176 m (7 holes) from the 2025 drill campaign – all from at the CV13 Pegmatite – are reported in this announcement (see Figure 1, Table 1, and Table 2). Results for lithium and tantalum for all drill holes completed in 2025 at Shaakichiuwaanaan have been previously reported (see news releases dated December 14, 2025 and January 21, 2026). All reported widths are core length (i.e., true width not known).

Helios Caesium Zone (NEW 2025 DISCOVERY)

The Helios Caesium Zone at CV13 is a new 2025 discovery, is located near surface, has approximate dimensions of 180 m x 80 m at ~1 to ~3 m thickness, and remains open in several directions (Figure 1, Table 1, Figure 2). At Helios, initial drill hole results have confirmed high-grades of caesium including an intercept of 1.0 m at 21.52% Cs₂O in drill hole CV25-975 (see news release dated February 3, 2026). Remaining drill hole results from 2025 are reported in this announcement and include the widest caesium intercept – also at strong grade – recorded to date at Helios:

• 4.9 m at 3.65% Cs2O including 1.7 m at 6.14% Cs2O (CV25-979), Figure 2.
• 0.5 m at 6.28% Cs2O (CV25-984).
• 2.6 m at 1.14% Cs2O (CV25-968).

Figure 2: Pollucite with late stage spodumene/pollucite (white) veining displaying classic “tapioca” texture (white blebs) at a depth of ~43.7 m in drill hole CV25-979 from the Helios Zone. Core grades 0.5 m at 2.33% Cs2O within a wider mineralized interval of 4.9 m at 3.65% Cs2O (39.0 m to 43.9 m)

New Discovery Indicates A Potential New Zone North of Vega

The final batch of drill core assays has resulted in the discovery of strong caesium grades located outside of the other known zones of mineralization at the CV13 Pegmatite (i.e., outside of Vega, Rigel, Helios). The intercept – 2.3 m at 4.65% Cs₂O (CV25-999) – is located approximately 70 m north of the currently defined Vega Caesium Zone and is closer to surface (~45 m vertical depth), indicating the presence of a new mineralized lens (Figure 1). The Company intends to follow-up on the mineralized intercept during its 2026 drill campaign.

Next Steps

Drill results for lithium, caesium, and tantalum have now been received and reported for all drill holes completed during the 2025 campaign (57,024 m over 245 holes). The geology team is currently interpreting and working with the data to advance the host rock and pegmatite geological models for the Project. The work is focused on the CV5 and CV13 pegmatites – including the Vega, Rigel, and Helios caesium zones – ahead of updates to their respective block models and subsequent Mineral Resource Estimates.

These revised models will underpin an updated Feasibility Study for the CV5 Pegmatite with the addition of tantalum as a co-product, as well as a Preliminary Economic Assessment for the broader Project inclusive of lithium, caesium, and tantalum. The Company is also actively advancing the permitting of an underground bulk sample of mineralized pegmatite at CV5.

Table 1: Core assay summary for caesium in drill holes reported herein at the CV13 Pegmatite.

Table 2: Attributes for drill holes reported herein at the CV13 Pegmatite.

Quality Assurance / Quality Control (QAQC)

Drill core was saw-cut with half-core sent for geochemical analysis and half-core remaining in the box for reference. A Quality Assurance / Quality Control protocol following industry best practices was incorporated into the program and included systematic insertion of quartz blanks and certified/standard reference materials into sample batches at a rate of approximately 5% each. Additionally, analysis of pulp-split sample duplicates was completed to assess analytical precision, and external (secondary) laboratory pulp-split duplicates were prepared at the primary lab for subsequent check analysis and validation.

All core samples collected were shipped to SGS Canada's laboratory in Val-d'Or, QC, for sample preparation (code PRP90 special) which includes drying at 105°C, crush to 90% passing 2 mm, riffle split 250 g, and pulverize 85% passing 75 microns. The pulps were shipped by air to SGS Canada's laboratory in Burnaby, BC, where the samples were homogenized and subsequently analyzed for multi-element (including Li, Ta, and Cs) using sodium peroxide fusion with ICP-AES/MS finish (codes GE_ICP91A50 and GE_IMS91A50). Overlimits for Cs were completed at SGS Canada's laboratory in Lakefield, ON, by borate-fusion XRF (code GC_XRF76V).

About Caesium

Mineral deposits of pollucite-hosted caesium are very rare globally and represent the most fractionated component of LCT pegmatite systems, which are effectively the only known primary economic source of caesium supply. Economic deposits of caesium pegmatite are typically on a smaller scale of <10 kt to 350 kt in size compared to deposits of lithium pegmatite that typically range in the millions of tonnes in size (<10 Mt and rarely over 100 Mt).

The market for caesium compounds and metals is largely opaque because it is not publicly traded like copper or gold, but rather through bi-lateral and term contracts. Further, product prices vary depending on their contained caesium form, purity and end-product use. As an example, caesium carbonate (Cs₂CO₃≥99%) currently trades at more than US$200/kg (excluding VAT, Price Sourcing – Shanghai Metal Markets). 

Caesium is currently supply constrained, with only limited sources supplying the global market. A discovery at the size, grade, and scale of Shaakichiuwaanaan has the potential to be a primary source of supply for global markets over the long-term. This includes existing applications for caesium in oil/gas drilling, medical imaging, emissions reduction, atomic clocks and precision GPS navigation, as well as new and potentially growing applications in the terrestrial solar panel industry. Caesium has been found to play a vital role in significantly improving next generation solar panel efficiency, stability, and life span. Additionally, the use of caesium in lithium-ion batteries to improve performance is actively being explored through use as an additive in certain cathode, anode, and electrolyte chemistries.

Qualified/Competent Person

The technical and scientific information in this news release that relates to the Mineral Resource  Estimate and exploration results for the Company's properties is based on, and fairly represents, information compiled by Mr. Darren L. Smith, M.Sc., P.Geo., who is a Qualified Person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects ("NI 43-101"), and member in good standing with the Ordre des Géologues du Québec (Geologist Permit number 01968), and with the Association of Professional Engineers and Geoscientists of Alberta (member number 87868). Mr. Smith has reviewed and approved the related technical information in this news release.

Mr. Smith is an Executive and Vice President of Exploration for PMET Resources Inc. and holds common shares, Restricted Share Units (RSUs), Performance Share Units (PSUs), and options in the Company.

The information in this news release that relates to the Mineral Reserve Estimate and Feasibility Study is based on, and fairly represents, information compiled by Mr. Frédéric Mercier-Langevin, Ing. M.Sc., who is a Qualified Person as defined by NI 43-101, and member in good standing with the Ordre des Ingénieurs du Québec. Mr. Mercier-Langevin has reviewed and approved the related technical information in this news release.

Mr. Mercier-Langevin is the Chief Operating and Development Officer for PMET Resources Inc. and holds common shares, RSUs, PSUs, and options in the Company.

About PMET Resources Inc.

PMET Resources Inc. is a pegmatite critical mineral exploration and development company focused on advancing its district-scale 100%-owned Shaakichiuwaanaan Property located in the Eeyou Istchee James Bay region of Quebec, Canada, which is accessible year-round by all-season road and proximal to regional hydro-power infrastructure.

In late 2025, the Company announced a positive lithium-only Feasibility Study on the CV5 Pegmatite for the Shaakichiuwaanaan Property and declared a maiden Mineral Reserve of 84.3 Mt at 1.26% Li₂O (Probable)³. The study outlines the potential for a competitive and globally significant high-grade lithium project targeting up to ~800 ktpa spodumene concentrate using a simple Dense Media Separation ("DMS") only process flowsheet. Further, the results highlight Shaakichiuwaanaan as a potential North American critical mineral powerhouse with significant opportunity for tantalum and caesium in addition to lithium.

The Project hosts a Consolidated Mineral Resource⁴ totalling 108.0 Mt at 1.40% Li₂O and 166 ppm Ta₂O₅ (Indicated) and 33.4 Mt at 1.33% Li₂O and 155 ppm Ta₂O₅ (Inferred), and ranks as a top ten lithium pegmatite globally in size. Additionally, the Project hosts the world's largest pollucite-hosted caesium pegmatite Mineral Resource at the Rigel and Vega zones with 0.69 Mt at 4.40% Cs₂O (Indicated), and 1.70 Mt at 2.40% Cs₂O (Inferred).

For further information, please contact us at info@pmet.ca or by calling +1 (604) 279-8709, or visit www.pmet.ca. Please also refer to the Company's continuous disclosure filings, available under its profile at www.sedarplus.ca and www.asx.com.au, for available exploration data.

This news release has been approved by

"KEN BRINSDEN"                              
Kenneth Brinsden, President, CEO, & Managing Director

Disclaimer for Forward-Looking Information

This news release contains "forward-looking statements" and "forward-looking information" within the meaning of applicable securities laws.

All statements, other than statements of present or historical facts, are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and assumptions and accordingly, actual results could differ materially from those expressed or implied in such statements. You are hence cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are typically identified by words such as "plan", "development", "growth", "continued", "intentions", "expectations", "emerging", "evolving", "strategy", "opportunities", "anticipated", "trends", "potential", "outlook", "ability", "additional", "on track", "prospects", "viability", "estimated", "reaches", "enhancing", "strengthen", "target", "believes", "next steps" or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. 

Forward-looking statements include, but are not limited to, statements concerning the interpretation of the results from exploration, the exploration and development potential of various zones the remaining interpretations from the 2025 drill campaign and future exploration work, including the anticipated results therefrom, the advancement of the host rock and pegmatite geological models for the Project, the bulk sample of mineralized pegmatite at CV5, which is currently being permitted, the preparation and release of an updated Feasibility Study for the CV5 Pegmatite with the addition of tantalum as a co-product, as well as a Preliminary Economic Assessment for the broader Project inclusive of lithium, caesium, and tantalum.

Forward-looking statements are based upon certain assumptions and other important factors that, if untrue, could cause actual results to be materially different from future results expressed or implied by such statements. There can be no assurance that forward-looking statements will prove to be accurate. Key assumptions upon which the Company's forward-looking information is based include, without limitation, the ability to make discoveries, the potential of each of tantalum, lithium, caesium as a co-product, , the ability to complete an updated Feasibility Study for the CV5 Pegmatite with the addition of tantalum as a co-product, as well as a Preliminary Economic Assessment for the broader Project inclusive of lithium, caesium, and tantalum, that proposed exploration work on the Property and the results therefrom will continue as expected, the accuracy of reserve and resource estimates, the classification of resources and the assumptions on which the reserve and resource estimates are based, long-term demand for lithium (spodumene), tantalum (tantalite), and caesium (pollucite)  supply, and that exploration and development results continue to support management's current plans for the Property's development.

Forward-looking statements are also subject to risks and uncertainties facing the Company's business, any of which could have a material adverse effect on the Company's business, financial condition, results of operations and growth prospects. Readers should review the detailed risk discussion in the Company's most recent Annual Information Form filed on SEDAR+, for a fuller understanding of the risks and uncertainties that affect the Company's business and operations.

Although the Company believes its expectations are based upon reasonable assumptions and has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking information will prove to be accurate. If any of the risks or uncertainties mentioned above, which are not exhaustive, materialize, actual results may vary materially from those anticipated in the forward-looking statements.

The forward-looking statements contained herein are made only as of the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable law. The Company qualifies all of its forward-looking statements by these cautionary statements.

Competent Person Statement (ASX Listing Rules)

The information in this news release that relates to the Feasibility Study ("FS") for the Shaakichiuwaanaan Project, which was first reported by the Company in a market announcement titled "PMET Resources Delivers Positive CV5 Lithium-Only Feasibility Study for its Large-Scale Shaakichiuwaanaan Project" dated October 20, 2025 (Montreal time) is available on the Company's website at www.pmet.ca, on SEDAR+ at www.sedarplus.ca and on the ASX website at www.asx.com.au. The production target from the Feasibility Study referred to in this news release was reported by the Company in accordance with ASX Listing Rule 5.16 on the date of the original announcement. The Company confirms that, as of the date of this news release, all material assumptions and technical parameters underpinning the production target in the original announcement continue to apply and have not materially changed.

The Mineral Resource and Mineral Reserve Estimates in this release were first reported by the Company in accordance with ASX Listing Rule 5.8 in market announcements titled "World's Largest Pollucite-Hosted Caesium Pegmatite Deposit" dated July 20, 2025 (Montreal time) and "PMET Resources Delivers Positive CV5 Lithium-Only Feasibility Study for its Large-Scale Shaakichiuwaanaan Project" dated October 20, 2025 (Montreal time) and are available on the Company's website at www.pmet.ca, on SEDAR+ at www.sedarplus.ca and on the ASX website at www.asx.com.au. The Company confirms that, as of the date of this news release, it is not aware of any new information or data verified by the competent person that materially affects the information included in the relevant announcement and that all material assumptions and technical parameters underpinning the estimates in the relevant announcement continue to apply and have not materially changed. The Company confirms that, as at the date of this announcement, the form and context in which the competent person's findings are presented have not been materially modified from the original market announcement.

Appendix 1 – JORC Code 2012 Table 1 (ASX Listing Rule 5.8.2)

Section 1 – Sampling Techniques and Data

Section 2 – Reporting of Exploration Results

Olivier Caza-Lapointe, Head, Investor Relations, T: +1 (514) 913-5264, E: ocazalapointe@pmet.ca

Photo - https://mma.prnasia.com/media2/2937230/PMET_Resources_Inc__Widest_Caesium_Drill_Intercept_to_Date_at_th.jpg?p=medium600
Photo - https://mma.prnasia.com/media2/2937231/PMET_Resources_Inc__Widest_Caesium_Drill_Intercept_to_Date_at_th.jpg?p=medium600
Logo - https://mma.prnasia.com/media2/2937233/PMET_Resources_Inc__Widest_Caesium_Drill_Intercept_to_Date_at_th.jpg?p=medium600

CEO and Chairman Retirement

The Company announced that Junsei Ryu retired from his role as Chief Executive Officer and Chairman of the Board effective March 18, 2026.  Mr. Ryu plans to continue to serve as an advisor to the Board for a 12‑month transition period to ensure an orderly handover of responsibilities.

"The Board is deeply grateful to Mr. Ryu for his exceptional leadership in taking the Company public in 2024, driving our expansion into Ethiopia and the U.S., and for his unwavering commitment to our customers, partners, and employees," said Alfred "Trey" Hickey, an Independent Director of TOYO. "He has positioned the Company on a strong footing, with a clear strategy and a robust balance sheet, and we wish him the very best in his retirement."

Appointment of New CEO and Chairman

Mr. Takahiko Onozuka is appointed as CEO and Chairman of the Board as of March 18, 2026. He is an accomplished global executive with over 40 years of experience in international finance, energy infrastructure, and decarbonization. He has strong track record in project and structured finance, business origination, risk management, and stakeholder engagement across Asia, Europe, the Middle East, and Africa.

Prior to joining the Company, he held senior roles at Japan Bank for International Cooperation ("JBIC") and Sumitomo Corporation, leading major cross‑border projects in oil and gas, power generation, liquefied natural gas, railways, and renewable energy. Since September 2025, he has served as General Manager of the Global Decarbonization Promoting Office at Abalance Corporation, driving key energy transition initiatives.

Mr. Onozuka holds a Bachelor of Laws (LL.B.) from Waseda University, has completed advanced coursework in physics and engineering at Tokyo Institute of Technology, and holds multiple nationally accredited certifications in energy management and power systems.

"I am honored to be chosen to lead TOYO at such an exciting moment for the Company and the solar industry," said Mr. Onozuka. "Building on the strong foundation the team has created, we will continue to invest in advanced solar technologies and resilient supply chains, deepen our strategic partnerships, and deliver sustainable, long‑term value for our shareholders."

About TOYO Co., Ltd.

TOYO is a solar solutions company committed to becoming a full-service solar solutions provider in the global market, integrating upstream production of wafers and silicon, midstream production of solar cells, downstream production of photovoltaic modules, and potentially other stages of the solar power supply chain. TOYO is well-positioned to produce high-quality solar cells at a competitive scale and cost.

Forward-Looking Statements

Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. The words "anticipate," "look forward to," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including factors discussed in the section entitled "Risk Factors" in TOYO's annual report on Form 20-F, as well as discussions of potential risks, uncertainties, and other important factors in TOYO's subsequent filings with the U.S. Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof. TOYO specifically disclaims any obligation to update any forward-looking statement, whether due to new information, future events, or otherwise. Readers should not rely upon the information on this page as current or accurate after its publication date.

Contact Information:

For TOYO Co., Ltd.
IR@toyo-solar.com

Crocker Coulson
Email: crocker.coulson@aummedia.org
Tel: (646) 652-7185

FY2025 Preliminary Performance Highlights

• Revenue: Delivering stronger than expected performance, the Company achieved approximately $427 million, beating the previously updated guidance range of $375–$400 million issued in September 2025 and reflecting substantial year-over-year growth. This was driven by increased production volumes and strong orders from utility-scale and commercial customers worldwide.
• Solar Cell Shipments: Approximately 4.5 GW, surpassing previously announced full-year target of 4.2–4.4 GW. Key contributors included the successful ramp-up and full utilization of the Company's 4 GW solar cell facility in Ethiopia, which began commercial production in 2025.
• Solar module shipments: Approximately 249MW, since commencing commercial production in October 2025.
• EBITDA: Approximately $96 million, supported by operational efficiencies, improved margins from scaled production, and cost optimizations across the supply chain.
• Net Income: Approximately $38 million. Net income includes a one-time share-based compensation of approximately $14 million. These preliminary results underscore TOYO's progress in building a resilient, vertically integrated solar value chain, with strategic facilities in Ethiopia and the United States enhancing supply chain security and competitiveness amid evolving trade dynamics.

"2025 was a transformative year for TOYO, as we delivered on our elevated guidance and made meaningful strides in global manufacturing scale," said Takahiko Onozuka, Chairman and CEO of TOYO. "The rapid ramp of our Ethiopia cell facility has strengthened our position to meet rising demand for reliable, cost-effective solar solutions. We are focused on further integration, innovation, and sustainable expansion to create long-term value for shareholders and stakeholders in the clean energy transition."

Earnings Call Schedule

TOYO will host the FY2025 financial results earnings conference call on March 31^st, 2026, 8:30 am ET.  

Date: Tuesday, March 31, 2026

Time: 8:30 AM ET

Live Webcast: https://events.q4inc.com/attendee/197358704

The FY 2025 earnings release and related investor deck will be available on the investor relations website at investors.toyo-solar.com prior to the event.

The dial in numbers for the conference call will be as follows:

About TOYO Co., Ltd.

TOYO is a solar solutions company committed to becoming a full-service solar solutions provider in the global market, integrating upstream production of wafers and silicon, midstream production of solar cells, downstream production of photovoltaic modules, and potentially other stages of the solar power supply chain. TOYO is well-positioned to produce high-quality solar cells at a competitive scale and cost.

Forward-Looking Statements

Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. The words "anticipate," "look forward to," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including factors discussed in the section entitled "Risk Factors" in TOYO's annual report on Form 20-F, as well as discussions of potential risks, uncertainties, and other important factors in TOYO's subsequent filings with the U.S. Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof. TOYO specifically disclaims any obligation to update any forward-looking statement, whether due to new information, future events, or otherwise. Readers should not rely upon the information on this page as current or accurate after its publication date.

Contact Information:

For TOYO Co., Ltd.
IR@toyo-solar.com

Crocker Coulson
Email: crocker.coulson@aummedia.org
Tel: (646) 652-7185

Immediately prior to the Disposition, OCI had beneficial ownership of, or control and direction over, 9,944,308 Shares, representing approximately 12.9% of the issued and outstanding Shares. As a result of the Disposition, OCI now owns or exercises control or direction over an aggregate of 6,612,962 Shares, representing approximately 8.6% of the issued and outstanding Shares.

A copy of the early warning report to be filed by OCI in connection with the Disposition will be available on Methanex's profile on SEDAR+ at www.sedarplus.ca. A copy may also be obtained by contacting OCI (details below).

About OCI Global

Learn more about OCI at www.oci-global.com. You can also follow OCI on LinkedIn.

Additional Information

OCI effected the Disposition for investment purposes. Depending on market conditions and other factors, including Methanex's business and financial condition, OCI may in future acquire securities of Methanex or sell some or all of the securities of Methanex that it may own at any such time.

Cautionary Statement on Forward-Looking Information

Certain information contained in this press release, including any information relating to OCI's investment in Methanex, constitutes "forward-looking statements". All statements, other than statements of historical fact, are forward-looking statements. The words "may" and "will" and similar expressions identify forward-looking statements. In particular, this press release contains forward-looking statements including, without limitation, with respect to the potential for OCI to acquire securities of Methanex in future or to dispose of some or all of such securities that OCI owns at any time. Forward-looking statements are necessarily based upon a number of assumptions, including material assumptions considered reasonable by OCI as at the date of this press release in light of management's experience and perception of current conditions and expected developments, and are inherently subject to significant business, economic, and competitive uncertainties and contingencies.

Many of these uncertainties and contingencies can affect our actual results and could cause actual results to differ materially from those expressed or implied in any forward-looking statements made by, or on behalf of, us. Readers are cautioned not to put undue reliance on forward-looking statements which are not guarantees of future events, and speak only as of the date made. All of the forward-looking statements made in this press release are qualified by these cautionary statements. OCI disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.

ONTARIO, Calif., March 13, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. ("Nature's Miracle" or the "Company") (OTCQB: NMHI), a leader in controlled environment agriculture, today announced that it is setting up an investor hotline at 1-800-816-3223.  This replaces a previously provided number. Or email inquiries to info@nature-miracle.com.

About Nature's Miracle Holding Inc.

Nature's Miracle (www.Nature-Miracle.com) is a growing agriculture technology company providing equipment and services to the Controlled Environment Agriculture ("CEA") industry, including vertical farming in North America. Through its two wholly-owned subsidiaries, Visiontech Group, Inc. and Hydroman, Inc., Nature's Miracle provides grow lights and hydroponic products to hundreds of indoor growers. The Company also maintains a robust pipeline to build commercial-scale greenhouses to meet the growing demand for fresh, local produce in North America. 

Important Information About Press Release

This press release includes information about the MOU. Other than specific provisions in the MOU, the MOU deal points, including the structure of the acquisition and the consideration to be offered, among other things, are not binding. This press release is intended to show the willingness of the parties to fulfill plans that complement their businesses. A transaction is final only upon the signing of a definitive agreement.

This press release contains a phone number for the Company but may not be available 24 hours a day, have limited personnel handling such communications. The Company reserves the right not to reply to harassment type messages and threats.

This press release does not contain all the information that should be considered concerning the stock of Nature's Miracle, its warrants, and its related businesses. The press release is not intended to form the basis of any investment decision or any other decision in respect to the securities of Nature's Miracle. More information can be obtained by writing directly to Nature's Miracle Holding Inc., 3281 E. Guasti Rd.#175., Ontario, CA 91761, attention Investor Information.

Forward-looking Statements

Except for historical information contained herein, this press release contains certain "forward-looking statements" within the meaning of the federal U.S. securities laws with respect to the MOU and business of Nature's Miracle; other future references such as the anticipated synergies resulting from the transactions contemplated by the MOU,  the services and markets of Nature's Miracle, our expectations regarding future growth, results of operations, performance, future capital and other expenditures, competitive advantages, business prospects and opportunities, future plans and intentions, results, level of activities, performance, goals or achievements or other future events. These forward-looking statements generally are identified by words such as "anticipate," "believe," "expect," "may," "could," "will," "potential," "intend," "estimate," "should," "plan," "predict," or the negative or other variations of such statements, reflect our management's current beliefs and assumptions and are based on the information currently available to our management. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual results or developments to differ materially from those expressed or implied by such forward-looking statements, including but not limited to: (i) the risk that the business and revenue prospects of Nature's Miracle may not materialize which may adversely affect the price of Nature's Miracle's securities; (ii) the occurrence of any unforeseen event that would impact continued listing of Nature's Miracle's securities on the Nasdaq exchange; (iii) changes in the competitive industries in which Nature's Miracle operates, variations in operating performance across competitors, changes in laws and regulations affecting Nature's Miracle's business and changes in the combined capital structure; (iv) the ability to implement business plans, forecasts and other expectations after the completion of the proposed transactions contemplated by the MOU; (v) the risk of downturns in the market and Nature's Miracle's industry including, but not limited to market prices of indoor grower's produce, transportation costs, competition with outdoor growers and demand in the consumer marketplace. For additional details on the uncertainties that may cause our actual results to be materially different than those expressed in our forward-looking statements, please review our prospectus/proxy statement included in our Registration Statement on Form S-4 on file with the Securities and Exchange Commission at www.sec.gov, particularly the information contained in the section entitled "Risk Factors." Forward-looking statements speak only as of the date on which they are made, and neither Nature's Miracle assume any obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements. Nature's Miracle does not give any assurance that the Company will achieve its expectations.

Non-solicitation

This press release is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the potential business combination or any other matter and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of Nature's Miracle, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended.